"Antigens, CD1d" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major histocompatibility complex class I-like protein that contains an IMMUNOGLOBULIN C1-SET DOMAIN. It plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS.
| Descriptor ID |
D055610
|
| MeSH Number(s) |
D23.050.301.264.035.100.500 D23.050.301.264.894.080.500 D23.101.100.110.100.500 D23.101.100.894.080.500
|
| Concept/Terms |
Antigens, CD1d- Antigens, CD1d
- CD1d Antigens
- CD1d Antigen
- Antigen, CD1d
- Cd1d Molecule
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD1d".
- Chemicals and Drugs [D]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Antigens, CD1 [D23.050.301.264.035.100]
- Antigens, CD1d [D23.050.301.264.035.100.500]
- Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
- Antigens, CD1 [D23.050.301.264.894.080]
- Antigens, CD1d [D23.050.301.264.894.080.500]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Antigens, CD1 [D23.101.100.110.100]
- Antigens, CD1d [D23.101.100.110.100.500]
- Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
- Antigens, CD1 [D23.101.100.894.080]
- Antigens, CD1d [D23.101.100.894.080.500]
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD1d".
This graph shows the total number of publications written about "Antigens, CD1d" by people in this website by year, and whether "Antigens, CD1d" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, CD1d" by people in Profiles.
-
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist. Org Biomol Chem. 2019 01 31; 17(5):1225-1237.
-
Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas. J Neurooncol. 2014 Nov; 120(2):293-301.
-
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33.
-
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clin Immunol. 2013 Oct; 149(1):55-64.
-
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin Immunol. 2011 Aug; 140(2):119-29.
-
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest. 2009 Jun; 119(6):1524-36.
-
Advances in basic and clinical immunology in 2006. J Allergy Clin Immunol. 2007 Aug; 120(2):263-70.
-
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia. 2003 Jun; 17(6):1068-77.
-
NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production. Eur J Immunol. 2002 Dec; 32(12):3453-62.
-
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol. 2001 Sep 15; 167(6):3114-22.